GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Swedish Orphan Biovitrum AB (MEX:SOBI N) » Definitions » Cyclically Adjusted Book per Share

Swedish Orphan Biovitrum AB (MEX:SOBI N) Cyclically Adjusted Book per Share : MXN122.93 (As of Jun. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Swedish Orphan Biovitrum AB's adjusted book value per share for the three months ended in Jun. 2025 was MXN223.526. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN122.93 for the trailing ten years ended in Jun. 2025.

During the past 12 months, Swedish Orphan Biovitrum AB's average Cyclically Adjusted Book Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 22.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 21.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Swedish Orphan Biovitrum AB was 24.50% per year. The lowest was 13.00% per year. And the median was 21.60% per year.

As of today (2025-07-18), Swedish Orphan Biovitrum AB's current stock price is MXN523.55284. Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2025 was MXN122.93. Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio of today is 4.26.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Swedish Orphan Biovitrum AB was 13.83. The lowest was 3.89. And the median was 5.65.


Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share Historical Data

The historical data trend for Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share Chart

Swedish Orphan Biovitrum AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 101.10 113.16 105.73 104.22

Swedish Orphan Biovitrum AB Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 107.98 96.83 104.22 119.12 122.93

Competitive Comparison of Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio falls into.


;
;

Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Swedish Orphan Biovitrum AB's adjusted Book Value per Share data for the three months ended in Jun. 2025 was:

Adj_Book= Book Value per Share /CPI of Jun. 2025 (Change)*Current CPI (Jun. 2025)
=223.526/132.8245*132.8245
=223.526

Current CPI (Jun. 2025) = 132.8245.

Swedish Orphan Biovitrum AB Quarterly Data

Book Value per Share CPI Adj_Book
201509 33.450 100.228 44.329
201512 33.671 100.276 44.600
201603 36.954 100.751 48.718
201606 41.530 101.019 54.605
201609 43.257 101.138 56.810
201612 42.693 102.022 55.583
201703 41.973 102.022 54.646
201706 44.114 102.752 57.025
201709 51.081 103.279 65.694
201712 55.624 103.793 71.183
201803 56.427 103.962 72.093
201806 62.181 104.875 78.753
201809 62.937 105.679 79.104
201812 69.563 105.912 87.239
201903 98.173 105.886 123.149
201906 99.280 106.742 123.540
201909 103.597 107.214 128.344
201912 109.867 107.766 135.414
202003 144.215 106.563 179.756
202006 149.534 107.498 184.765
202009 151.777 107.635 187.297
202012 155.669 108.296 190.928
202103 161.693 108.360 198.199
202106 162.454 108.928 198.094
202109 167.385 110.338 201.497
202112 169.472 112.486 200.114
202203 160.037 114.825 185.123
202206 157.488 118.384 176.699
202209 149.129 122.296 161.967
202212 160.788 126.365 169.007
202303 154.184 127.042 161.202
202306 145.305 129.407 149.143
202309 159.406 130.224 162.590
202312 164.950 131.912 166.091
202403 168.319 132.205 169.107
202406 185.319 132.716 185.471
202409 207.911 132.304 208.728
202412 222.702 132.987 222.430
202503 229.431 132.825 229.431
202506 223.526 132.825 223.526

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Swedish Orphan Biovitrum AB  (MEX:SOBI N) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=523.55284/122.93
=4.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Swedish Orphan Biovitrum AB was 13.83. The lowest was 3.89. And the median was 5.65.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Swedish Orphan Biovitrum AB Business Description

Address
Tomtebodavagen 23 A, Solna, Stockholm, SWE, SE-112 76
Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) in 2006 on long-acting hemophilia factor replacement programs. Biovitrum acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. Sobi launched hemophilia products Alprolix and Eloctate in Europe in 2016, and Altuvoct in 2024. Sobi has been building its immunology pipeline (rare-disease drug Gamifant, US rights to RSV antibodies Synagis and Beyfortus, gout drug SEL-212, complement drug Aspaveli) and a broader hematology pipeline (thrombocytopenia drug Doptelet, blood cancer drug Zynlonta, myelofibrosis drug Vonjo).

Swedish Orphan Biovitrum AB Headlines

No Headlines